Journal of Literature Pharmacy Sciences

The Role of Crucial Biochemical Parameters and Key Gene Polymorphisms in the One-Carbon Pathway in Parkinson's Disease: Case-Control Study
Tek Karbon Yolağındaki Önemli Biyokimyasal Parametrelerin ve Gen Polimorfizmlerinin Parkinson Hastalığındaki Rolü: Olgu Kontrol Çalışması
Mevlüt ULUKAYAa , Aylin ELKAMAa , Gürdal ORHANb , Bensu KARAHALİLa,c
aGazi University Faculty of Pharmacy, Department of Toxicology, Ankara, Türkiye
bAnkara Bilkent City Hospital, Clinic of Neurology, Ankara, Türkiye
cEastern Mediterranean University Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Famagusta, TRNC
J Lit Pharm Sci. 2024;13(3):141-50
doi: 10.5336/pharmsci.2024-102989
Article Language: EN
Full Text
ABSTRACT
 Objective: Parkinson's disease (PD) is the second most common neurodegenerative disease. The cause of PD is shown to be the decrease or degradation of dopaminergic activity in the brainstem region, which is thought to be triggered by environmental factors, aging, infectious agents, and other pathological conditions. Abnormalities in the folate-mediated one-carbon pathway may play a role in the pathophysiology of PD as it increases total homocysteine (Hcy) levels. We aimed to show possible associations between folate, Hcy, cysteine (Cys), and vitamin B12 levels, which function in the one-carbon pathway, and PD risk. Furthermore, the effect of genetic polymorphism of MTHFR and MTR, which are involved in the one-carbon pathway, on PD risk was investigated. Material and Methods: 108 patients diagnosed with PD and 97 healthy volunteers participated in this study. The biochemical parameters were measured by ELISA, and genetic polymorphisms analyzed by polymerase chain reaction-restriction fragment length polymorphism. Results: After adjustment for confounding factors such as age, smoking habit, and gender, there was a statistically significant increase in the risk of PD as folic acid levels increased and as vitamin B12 and Hcy levels decreased. These findings suggest that extra folic acid intake in the patients' diets may have been the cause of these findings. Higher Hcy levels were observed in PD patients with the MTHFR C677T TT genotype and the MTR A2756G GG genotype. However, this difference was not significant. No effect of Cys levels on PD risk was observed. Conclusion: MTHFR C677T and MTR A2756G gene polymorphisms were not found to be risk factors for PD.

Keywords: Folic acid; genetic polymorphism; homocysteine; one-carbon group transferases; Parkinson's disease
ÖZET
 Amaç: Parkinson hastalığı (PH) en yaygın ikinci nörodejeneratif hastalıktır. PH'nin nedeni, çevresel faktörler, yaşlanma, enfeksiyöz ajanlar ve diğer patolojik koşullar tarafından tetiklendiği düşünülen beyin sapı bölgesindeki dopaminerjik aktivitenin azalması veya bozulması olarak gösterilmektedir. Folat aracılı tek karbon yolağındaki anormallikler, toplam homosistein [homocysteine (Hcy)] seviyelerini artırdığı için PH patofizyolojisinde rol oynayabilir. Tek karbon yolağında işlev gören folat, Hcy, sistein [cysteine (Cys)] ve vitamin B12 düzeyleri ile PH riski arasındaki olası ilişkileri göstermeyi amaçladık. Ayrıca, tek karbon yolunda yer alan MTHFR ve MTR genetik polimorfizminin PH riski üzerindeki etkisi araştırılmıştır. Gereç ve Yöntemler: Bu çalışmaya 108 PH tanısı almış hasta ve 97 sağlıklı gönüllü katılmıştır. Biyokimyasal parametreler ELISA ile ölçülmüş ve genetik polimorfizmler polimeraz zincir reaksiyonu-restriksiyon parça uzunluk polimorfizmi ile analiz edilmiştir. Bulgular: Yaş, sigara alışkanlığı ve cinsiyet gibi karıştırıcı faktörler ayarlandıktan sonra, artan folik asit seviyeleri ve azalan B12 vitamini ve Hcy seviyeleri ile PH riski istatistiksel olarak anlamlı şekilde artmıştır. Bu bulgular, hastaların diyetlerinde fazladan folik asit alımının bu bulgulara neden olmuş olabileceğini düşündürmektedir. MTHFR C677T TT genotipine ve MTR A2756G GG genotipine sahip PH hastalarında daha yüksek Hcy seviyeleri gözlenmiştir. Ancak bu fark anlamlı bulunmamıştır. Cys düzeylerinin PH riski üzerinde etkisi gözlenmemiştir. Sonuç: MTHFR C677T ve MTR A2756G gen polimorfizmleri PH için risk faktörü olarak bulunmamıştır.

Anahtar Kelimeler: Folik asit; genetik polimorfizm; homosistein; tek karbon grup transferazlar; Parkinson hastalığı
REFERENCES:
  1. Kouli A, Torsney KM, Kuan WL. Parkinson's disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson's Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018. Chapter 1. [PubMed] 
  2. Türk Nöroloji Derneği. Parkinson Hastalığı. 2014. Erişim tarihi: 15 Şubat 2024. Erişim linki: [Link] 
  3. Cerri S, Mus L, Blandini F. Parkinson's disease in women and men: what's the difference? J Parkinsons Dis. 2019;9(3):501-15. [Crossref]  [PubMed]  [PMC] 
  4. Ulucan K, Karahan M, Sağlam E. Folik asit metabolizmasının biyokimyasal ve moleküler açıdan Parkinson, Alzheimer, bipolar ve şizofrenik bozukluklara etkisi [Biochemical and molecular effects of folic acid metabolism to Parkinson, Alzheimer, bipolar and schizophrenic diseases]. Anatolian Journal of Psychiatry. 2013;14(4):378-82. [Crossref] 
  5. İşbilen N, Küçükkılınç TT. Folat metabolizmasının nörodejeneratif hastalıklardaki rolü [The role of folate metabolism in neurodegenerative diseases]. FABAD Journal of Pharmaceutical Sciences. 2020;45(3):243-52. [Link] h
  6. Diao HM, Song ZF, Xu HD. Association between MTHFR genetic polymorphism and Parkinson's disease susceptibility: a meta-analysis. Open Med (Wars). 2019;14:613-24. [Crossref]  [PubMed]  [PMC] 
  7. Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol. 2007;165(1):1-13. [Crossref]  [PubMed] 
  8. Murakami K, Mizoue T, Sasaki S, Ohta M, Sato M, Matsushita Y, et al. Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition. 2008;24(2):140-7. [Crossref]  [PubMed] 
  9. Mansoori N, Tripathi M, Luthra K, Alam R, Lakshmy R, Sharma S, et al. MTHFR (677 and 1298) and IL-6-174 G/C genes in pathogenesis of Alzheimer's and vascular dementia and their epistatic interaction. Neurobiol Aging. 2012;33(5):1003.e1-8. [Crossref]  [PubMed] 
  10. Zhu H, Wicker NJ, Shaw GM, Lammer EJ, Hendricks K, Suarez L, et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab. 2003;78(3):216-21. [Crossref]  [PubMed] 
  11. Zhao Y, Tian D, Guo N, Zhang C, Zhu R, Liu X, et al. Investigating the causality of metabolites involved in one-carbon metabolism with the risk and age at onset of Parkinson's disease: a two-sample mendelian randomization study. Neurobiol Aging. 2021;108:196-9. [Crossref]  [PubMed] 
  12. Temel İ, Özerol E. Homosistein metabolizma bozuklukları ve vasküler hastalıklarla ilişkisi [Homocysteine metabolism disorders and their relationship with vascular diseases]. İnönü Üniversitesi Tıp Fakültesi Dergisi. 2002;9(2):149-57. [Link] 
  13. Keser N, Pazarbaşı A, Özpak L. Metilentetrahidrofolar redüktaz aktivitesi ve folat metabolizması [Methylenetetrahydrofolate reductase activity and folate metabolism]. Archives Medical Review Journal. 2014;23(2):237-56. [Crossref] 
  14. Karahalil B, Kocabas NA, Ozçelik T. DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res. 2006;26(6C):4955-8. [PubMed] 
  15. Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct. 2005;23(1):51-4. [Crossref]  [PubMed] 
  16. De Marco P, Calevo MG, Moroni A, Arata L, Merello E, Finnell RH, et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet. 2002;47(6):319-24. [Crossref]  [PubMed] 
  17. Graydon JS, Claudio K, Baker S, Kocherla M, Ferreira M, Roche-Lima A, et al. Ethnogeographic prevalence and implications of the 677C>T and 1298A>C MTHFR polymorphisms in US primary care populations. Biomark Med. 2019;13(8):649-61. [Crossref]  [PubMed]  [PMC] 
  18. Kondo A, Fukuda H, Matsuo T, Shinozaki K, Okai I. C677T mutation in methylenetetrahydrofolate reductase gene and neural tube defects: should Japanese women undergo gene screening before pregnancy? Congenit Anom (Kyoto). 2014;54(1):30-4. [Crossref]  [PubMed] 
  19. Chen H, Huang X, Guo X, Mailman RB, Park Y, Kamel F, et al. Smoking duration, intensity, and risk of Parkinson disease. Neurology. 2010;74(11):878-84. [Crossref]  [PubMed]  [PMC] 
  20. Tanaka K, Miyake Y, Fukushima W, Sasaki S, Kiyohara C, Tsuboi Y, et al; Fukuoka Kinki Parkinson's disease Study Group. Active and passive smoking and risk of Parkinson's disease. Acta Neurol Scand. 2010;122(6):377-82. [Crossref]  [PubMed] 
  21. Wang W, Jiao XH, Wang XP, Sun XY, Dong C. MTR, MTRR, and MTHFR gene polymorphisms and susceptibility to nonsyndromic cleft lip with or without cleft palate. Genet Test Mol Biomarkers. 2016;20(6):297-303. [Crossref]  [PubMed]  [PMC] 
  22. Zahra C, Tabone C, Camilleri G, Felice AE, Farrugia R, Bezzina Wettinger S. Genetic causes of Parkinson's disease in the Maltese: a study of selected mutations in LRRK2, MTHFR, QDPR and SPR. BMC Med Genet. 2016;17(1):65. [Crossref]  [PubMed]  [PMC] 
  23. Wu YL, Ding XX, Sun YH, Yang HY, Sun L. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis. J Neurol Sci. 2013;335(1-2):14-21. [Crossref]  [PubMed] 
  24. Vallelunga A, Pegoraro V, Pilleri M, Biundo R, De Iuliis A, Marchetti M, et al. The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease. Neurol Sci. 2014;35(1):73-7. [Crossref]  [PubMed] 
  25. Triantafyllou NI, Nikolaou C, Boufidou F, Angelopoulos E, Rentzos M, Kararizou E, et al. Folate and vitamin B12 levels in levodopa-treated Parkinson's disease patients: their relationship to clinical manifestations, mood and cognition. Parkinsonism Relat Disord. 2008;14(4):321-5. [Crossref]  [PubMed] 
  26. Jameson GNL. Iron, cysteine and Parkinson's disease. Monatshefte für Chemie - Chemical Monthly. 2011;142:325-9. [Link] 
  27. Kumudini N, Uma A, Naushad SM, Mridula R, Borgohain R, Kutala VK. Association of seven functional polymorphisms of one-carbon metabolic pathway with total plasma homocysteine levels and susceptibility to Parkinson's disease among South Indians. Neurosci Lett. 2014;568:1-5. [Crossref]  [PubMed] 
  28. Guéant-Rodriguez RM, Juilliére Y, Candito M, Adjalla CE, Gibelin P, Herbeth B, et al. Association of MTRRA66G polymorphism (but not of MTHFR C677T and A1298C, MTRA2756G, TCN C776G) with homocysteine and coronary artery disease in the French population. Thromb Haemost. 2005;94(3):510-5. [Crossref]  [PubMed] 
  29. Emre R, Özkan S, Cantürk K, Aslan H, Özdemir M, Aldemir Ö, et al. Investigation of the association of homocysteine and MTHFR polymorphisms and treatment options in Parkinson's disease in central anatolian region. International Journal of Basic Clinical Medicine. 2015;3(3):98-105. [Link] 
  30. Emre R. Parkinson hastalığı tanısı alan olgularda metilentetrahidrofolat redüktaz geni polimorfizmlerinin araştırılması [Yüksek lisans tezi]. Eskişehir: Eskişehir Osmangazi Üniversitesi; 2011. [Erişim tarihi: 15 Şubat 2024]. Erişim linki: Erişim linki: [Link] 
  31. Müller T, Werne B, Fowler B, Kuhn W. Nigral endothelial dysfunction, homocysteine, and Parkinson's disease. Lancet. 1999;354(9173):126-7. [Crossref]  [PubMed] 
  32. Gürsoy G, Yüksel G, Çetinkaya Y, Hasırcı Bayır BR, Tireli H. Effect of homocysteine levels on cognitive and motor performance in patients with parkinson's disease. Türkiye Klinikleri Journal of Neurology. 2018;13(3):57-61. [Crossref] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com